Skip to main content
OpenTrials

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

467 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Recruiting

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

NCT06824103

Conditions
Chronic Graft vs. Host Disease, Corticosteroid-refractory Chronic Graft vs. Host Disease, Graft vs Host Disease, +2 more
Locations
  • Novartis Investigative Site Hefei, Anhui, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Nanning, Guangxi, China
View all 22 locations
View Trial Details
Recruiting

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

NCT07569653

Conditions
Cytomegalovirus Disease, Cytomegalovirus Infections, DNA Virus Infections, +6 more
Locations
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

NCT05675930

Conditions
GVHD, Graft vs Host Disease, Graft-Versus-Host Disease, +2 more
Locations
  • National Institute of Health (Data Collection AND Specimen Analysis) Bethesda, Maryland, United States
  • Memorial Sloan Kettering at Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Bergen (Consent only) Montvale, New Jersey, United States
View Trial Details
Recruiting

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

NCT06615050

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Stanford Cancer Center Palo Alto, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

NCT04380740

Conditions
Graft vs Host Disease, Immune System Diseases
Locations
  • City Of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University/Winship Cancer Center Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View all 15 locations
View Trial Details

Related conditions